Salvinorin A Produces Cerebrovasodilation through Activation of Nitric Oxide Synthase, &kgr; Receptor, and Adenosine Triphosphate–sensitive Potassium Channel

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Anesthesiology

• Publication date

  2011-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/ALN.0b013e318204e029PMID 21245734PMCID PMC3387285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage.

  2010cited by this paper
• ATP‐sensitive potassium channels: A promising target for protecting neurovascular unit function in stroke

  2010cited by this paper
• KATP channel openers protect mesencephalic neurons against MPP+‐induced cytotoxicity via inhibition of ROS production

  2010cited by this paper
• Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats

  2010cited by this paper
• Potential anxiolytic‐ and antidepressant‐like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents

  2009cited by this paper
• Molecular biology of KATP channels and implications for health and disease

  2009cited by this paper
• In vitro stability and metabolism of salvinorin A in rat plasma

  2009cited by this paper
• Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil

  2009cited by this paper
• Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals.

  2009cited by this paper
• Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen.

  2009cited by this paper
• Experimental Model of Lacunar Infarction in the Gyrencephalic Brain of the Miniature Pig: Neurological Assessment and Histological, Immunohistochemical, and Physiological Evaluation of Dynamic Corticospinal Tract Deformation

  2008cited by this paper
• Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans

  2008cited by this paper
• Physiological roles of K+ channels in vascular smooth muscle cells.

  2008cited by this paper
• Kir6.2-containing ATP-sensitive potassium channels protect cortical neurons from ischemic/anoxic injury in vitro and in vivo.

  2007cited by this paper
• Salvinorin A: from natural product to human therapeutics.

  2006cited by this paper
• Neuroprotective Effect of Selective Kappa Opioid Receptor Agonist is Gender Specific and Linked to Reduced Neuronal Nitric Oxide

  2006cited by this paper
• Large Animal Models of Traumatic Injury to the Immature Brain

  2006cited by this paper
• Salvinorin A: a novel and highly selective kappa-opioid receptor agonist.

  2004cited by this paper
• Remifentanil Update

  2004cited by this paper
• Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats.

  2003cited by this paper
• Kappa-opioid receptor stimulation contributes to aortic artery dilation through activation of K(ATP) channel in the rats.

  2003cited by this paper
• Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.

  2002cited by this paper
• Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

  2002cited by this paper
• Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans

  2001cited by this paper
• The role of nitric oxide in opioid-induced pial artery vasodilation.

  1995cited by this paper
• The cardiovascular and central nervous system effects in the human of U-62066E

  1994cited by this paper
• PTAKALIM PROTECTS AGAINST HYPOXIC BRAIN INJURY THROUGH ULTIPLE PATHWAYS ASSOCIATED WITH ATP-SENSITIVE OTASSIUM CHANNELS

  year unknowncited by this paper

• The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies

  2025cites this paper
• Salvinorin A and Salvia divinorum: Toxicology, Pharmacological Profile, and Therapeutic Potential

  2025cites this paper
• Emerging Psychotropic Drug for the Treatment of Trigeminal Pain: Salvinorin A

  2024cites this paper
• Advances of phytotherapy in ischemic stroke targeting PI3K/Akt signaling

  2023cites this paper
• Bedside to bench: the outlook for psychedelic research

  2023cites this paper
• Salvinorin A for Stroke Rescue Purposes

  2022cites this paper
• Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects

  2021cites this paper
• Kappa opioid receptors internalization is protective against oxygen-glucose deprivation through β-arrestin activation and Akt-mediated signaling pathway.

  2020cites this paper
• Bibliometric analysis of potassium channel research

  2019cites this paper
• Salvinorin A as a Potential Medication for Stroke

  2019cites this paper
• Oxycodone suppresses the apoptosis of hippocampal neurons induced by oxygen-glucose deprivation/recovery through caspase-dependent and caspase-independent pathways via κ- and δ-opioid receptors in rats.

  2019cites this paper
• Salvinorin A preserves cerebral pial artery autoregulation after forebrain ischemia via the PI3K/AKT/cGMP pathway

  2018cites this paper
• Salvinorin A ameliorates cerebral vasospasm through activation of endothelial nitric oxide synthase in a rat model of subarachnoid hemorrhage

  2018cites this paper
• The Use of Salvia divinorum from a Mazatec Perspective

  2018cites this paper
• The neuroprotective role of the brain opioid system in stroke injury.

  2018cites this paper
• Pharmacology and Structure-Activity Relationship of Natural Products With Psychoactive Effects From Salvia divinorum, Mitragyna speciosa, and Ayahuasca

  2017cites this paper
• The Role of &kgr; Opioid Receptor in Brain Ischemia

  2016cites this paper
• Enzyme Immunoassay for Salvinorin A (a Main Component in Salvia divinorum)

  2016cites this paper
• Highly selective non-opioid kappa opioid receptor (KOR) agonist salvinorin A protects against forebrain ischemia-induced brain injury in rats.

  2016cites this paper
• Salvinorin A: A Mini Review of Physical and Chemical Properties Affecting Its Translation from Research to Clinical Applications in Humans

  2014cites this paper
• Salvinorin A decreases mortality and improves neurological outcome in a neonatal mouse hypoxia model

  2014cites this paper
• Kappa Opioid Receptor Agonist and Brain Ischemia.

  2014cites this paper
• Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.

  2014cites this paper
• Translational Perioperative and Pain Medicine

  2014cites this paper
• Chapter 2 – Terpenes

  2013cites this paper
• Development of an enzyme immunoassay using a monoclonal antibody against the psychoactive diterpenoid salvinorin A.

  2013cites this paper
• Herkinorin dilates cerebral vessels via kappa opioid receptor and cyclic adenosine monophosphate (cAMP) in a piglet model.

  2013cites this paper
• Salvinorin A pretreatment preserves cerebrovascular autoregulation after brain hypoxic/ischemic injury via extracellular signal-regulated kinase/mitogen-activated protein kinase in piglets.

  2012cites this paper
• Endogenous opiates and behavior: 2011.

  2012cites this paper
• Salvinorin A Administration after Global Cerebral Hypoxia/Ischemia Preserves Cerebrovascular Autoregulation via Kappa Opioid Receptor in Piglets

  2012cites this paper